Abstracts - faqs.org

Abstracts

Health

Search abstracts:
Abstracts » Health

Medicare and erythropoietin

Article Abstract:

Congress consideration to eliminate financial incentives might lead to the overuse of epoetin (erythropoietin) and other separately billable drugs by establishing a combined payment system for all end-stage renal disease (ESRD) services. The data from the patient safety survey indicate that about half of patients undergoing dialysis in the United States have their hemoglobin levels maintained at values above the maximum target specified in the product labeling for erythropoiesis-stimulating agents.

Author: Steinbrook, Robert
Publisher: Massachusetts Medical Society
Publication Name: The New England Journal of Medicine
Subject: Health
ISSN: 0028-4793
Year: 2007
Government domestic functions, United States. Congress, Dosage and administration, Erythropoietin, Medicare, Health policy

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Facing the diabetes epidemic: Mandatory reporting of glycosylated hemoglobin values in New York City

Article Abstract:

The diabetes epidemic is rising fast in the US, with acute and chronic complications, disability, and death and the primary culprits are poor glycemic control over long term and major risk factors, such as hypertension, cigarette smoking, obesity and elevated levels of cholesterol or blood lipids. The New York City Board of Health has approved mandatory electronic reporting of glycosylated hemoglobin values by laboratories to the Department of Health and Mental Hygiene.

Author: Steinbrook, Robert
Publisher: Massachusetts Medical Society
Publication Name: The New England Journal of Medicine
Subject: Health
ISSN: 0028-4793
Year: 2006
Hypertension, Risk factors, Development and progression, Diabetes, Diabetes mellitus, Obesity

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


The potential of human papillomavirus vaccines

Article Abstract:

The US Food and Drug Administration (FDA) is conducting a review of Merck's investigational human papillomavirus (HPV) vaccine, which would represent a major public health advance against cervical cancer and other less common cancers. The potential behavioral consequences of vaccinating adolescents against a sexually acquired infection and the public reaction are discussed.

Author: Steinbrook, Robert
Publisher: Massachusetts Medical Society
Publication Name: The New England Journal of Medicine
Subject: Health
ISSN: 0028-4793
Year: 2006
Product development, Pharmaceutical preparations, Pharmaceutical industry, Prevention, Drug therapy, Cervical cancer, Papillomavirus infections, Viral vaccines, Merck & Company Inc.

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Subjects list: United States
Similar abstracts:
  • Abstracts: Hormone in the hot seat. Teams trail genes for human 'stemness'. Asia's big problem
  • Abstracts: Stress and your health. The diet that can save your life. What's your healthiest weight?
  • Abstracts: Incontinence and falls in older people: Is there a link? Taking the stigma of urinary incontinence. Call to screen for atrial fibrillation
  • Abstracts: Will care checks raise standards? An overview of the new resuscitation guidelines. New guideline on preventing and managing pressure ulcers
  • Abstracts: Medicare prescription drug coverage gap: Navigating the "doughnut hole" with patients. Neurohumoral features of myocardial stunning due to sudden emotional stress
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.
Some parts © 2025 Advameg, Inc.